SCHEMBL20127175

SCHEMBL20127175

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(C4(c5ccccc5)c5ccccc5-c5ccc6c(ccc7ccccc76)c54)cc3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.38
KMT2A Q03164 7/20 0.38
ALDH1A1 P00352 7/20 0.38
HPGD P15428 7/20 0.38
MEN1 O00255 6/20 0.38
NTSR1 P30989 1/20 0.38
KDM4E B2RXH2 5/20 0.37
LMNA P02545 3/20 0.37
GLA P06280 1/20 0.37
MAPK1 P28482 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127183 1.00 MAPT (0.38) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL20127184 0.94 HPGD (0.40) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL20127172 0.94 HPGD (0.40) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL20127182 0.93 MAPT (0.37) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22868954 0.91 MAPT (0.36) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22868955 0.88 MAPT (0.34) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22868953 0.88 MAPT (0.34) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22868952 0.88 CYP1A1 (0.40) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22868500 0.87 PDK2 (0.37) MAPTKMT2AALDH1A1HPGDMEN1
SCHEMBL22869058 0.87 MAPT (0.40) MAPTKMT2AALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2020-08-18 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 MAPT 1073/4885KMT2A 714/4885ALDH1A1 526/4885
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 MAPT 1073/4885KMT2A 714/4885ALDH1A1 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.